Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati

BenzingaApr 17 09:13 ET

Awakn Life Sciences Inks Licensing Partnership Deal With Oklahoma-based Clinic

Seeking AlphaApr 3 08:41 ET

Canadian Securities Exchange Reports February 2024 Performance Figures

Yahoo FinanceMar 15 07:41 ET

CSE Bulletin: New Listing - Awakn Life Sciences Corp. (AWKN)

Toronto, Ontario--(Newsfile Corp. - Le 9 février/February 2024) - The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure documents will be av

newsfileFeb 12 13:52 ET

UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center

The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ:CMPS) for Treatment-Resistant Depression and Awakn Life S

BenzingaNov 15, 2023 16:20 ET

U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy

Professor David Nutt, a cognitive sciences, addiction, cannabis and psychedelics researcher, has been ranked the #1 psychopharmacologist by ScholarGPS, a California-based American company owned and op

BenzingaOct 15, 2023 20:06 ET